Israel Technion Professor Marcelle Machluf has developed tumor-shrinking technology using normally “good” mesenchymal stem cells that tumors hi-jack to help them grow. Machluf’s team removed the cells’ contents and filled the membranes with chemotherapy.  They lure and destroy tumors. https://www.timesofisrael.com/technion-professor-creates-army-of-cell-ghosts-to-battle-deadliest-cancers/

Israel’s aMoon fund, has invested $5 million in the new NanoGhost anti-cancer therapy of Technion Professor Marcelle Machluf. (reported here previously). In lab tests NanoGhost reduced small lung carcinoma, prostate, and pancreatic cancer tumors, by as much as 85%. https://www.timesofisrael.com/ghost-cell-startup-that-targets-deadliest-cancers-gets-funding-boost

Technion scientists are using their NanoGhost technology (reported here) to send NanoGhost stem cells into the lungs. The coronavirus cells then bind with the NanoGhost decoy cells rather than the cells in the lung, thus reducing the ability of the … Continue reading →

Israel’s Technion and New York University’s Langone Medical Center have begun a research project, targeting metastatic melanoma and mesothelioma.  They will test the ability of a nanotechnology based on so-called “nanoghosts” using stem cells to home in on cancer cells. … Continue reading →